dr. hurvitz on the lack of predictive biomarkers in her2 breast cancer
Published 3 years ago • 121 plays • Length 1:39Download video MP4
Download video MP3
Similar videos
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:22
dr. hurvitz on the findings of destiny-breast01 in her2 metastatic breast cancer
-
1:11
dr. hurvitz on importance of biosimilars in her2 breast cancer
-
5:29
hr-positive breast cancer: predictive biomarkers
-
1:26
dr. hurvitz on unmet needs in her2 breast cancer
-
1:19
dr. hurvitz on the potential global impact of biosimilars in breast cancer
-
1:38
dr. hurvitz on the impact of biosimilars
-
1:46
dr. hurvitz on biosimilars in breast cancer
-
2:03
dr. hurvitz on novel agents in her2-positive breast cancer
-
2:01
dr. hurvitz on her2-targeted therapies in breast cancer
-
1:35
dr. hurvitz on therapeutics for her2 metastatic breast cancer
-
0:58
dr. hurvitz on treatment options for her2-positive breast cancer
-
2:00
dr. hurvitz on neomonarch trial for hr breast cancer
-
2:00
dr. hurvitz on treatment hypotheses for tnbc
-
11:23
introduction: biomarkers in breast cancer
-
1:45
identifying novel predictive biomarkers in breast cancer
-
1:40
dr. o'shaughnessy on the future of breast cancer biomarkers
-
1:26
the search for biomarkers in metastatic breast cancer
-
1:12
dr. tripathy discusses breast cancer biomarkers